Compare ZD & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZD | ATRC |
|---|---|---|
| Founded | 1995 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 1999 | 2005 |
| Metric | ZD | ATRC |
|---|---|---|
| Price | $52.16 | $34.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $39.71 | ★ $51.17 |
| AVG Volume (30 Days) | 737.6K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $1,364,028,000.00 | $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | $2.16 | $12.21 |
| P/E Ratio | $89.59 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $22.45 | $25.36 |
| 52 Week High | $54.75 | $43.18 |
| Indicator | ZD | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 70.23 |
| Support Level | $39.78 | $34.16 |
| Resistance Level | N/A | $34.38 |
| Average True Range (ATR) | 1.84 | 1.50 |
| MACD | 0.20 | 0.62 |
| Stochastic Oscillator | 73.33 | 91.94 |
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.